Avai Bio (AVAI) Invested Capital (2018 - 2026)

Avai Bio has disclosed Invested Capital across 9 years of filings, most recently posting -$2.5 million for Q2 2026.

• In Q2 2026, Invested Capital fell 45.62% year-over-year to -$2.5 million; the TTM figure through Jun 2026 stood at -$2.5 million (down 45.62% YoY), while the FY2026 annual figure was -$2.3 million, down 93.17% from the prior year.
• Invested Capital came in at -$2.5 million for Q2 2026 at Avai Bio, down from -$2.3 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.3 million in Q4 2024 to a low of -$2.5 million in Q2 2026.
• Average Invested Capital over 5 years is -$748921.0, with a median of -$864593.0 recorded in 2023.
• Year-over-year, Invested Capital plunged 3826.69% in 2022 and surged 361.55% in 2024.
• Over 5 years, Invested Capital stood at -$301154.0 in 2022, then slumped by 234.18% to -$1.0 million in 2023, then soared by 332.52% to $2.3 million in 2024, then sank by 195.92% to -$2.2 million in 2025, then retreated by 9.88% to -$2.5 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were -$2.5 million in Q2 2026, -$2.3 million in Q1 2026, and -$2.2 million in Q4 2025.